Evaluating the Efficacy of Modified BeEAM(Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country

Background: High-dose chemotherapy followed by Autologous SCT (stem cell transplantation) is a treatment of choice for relapsed and refractory lymphoma. Due to cost, toxicity, and shortage of Carmustine, we decided to conduct a phase 2 clinical trial to evaluate the safety and efficacy of Bendamusti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramzi, Mani, Vafaie, Elaheh, Haghighinejad, Hourvash, Imran, Hashim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452946/
https://www.ncbi.nlm.nih.gov/pubmed/37637764
http://dx.doi.org/10.18502/ijhoscr.v17i2.12647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452946/
https://www.ncbi.nlm.nih.gov/pubmed/37637764
http://dx.doi.org/10.18502/ijhoscr.v17i2.12647

Ejemplares similares